PUBLISHER: 360iResearch | PRODUCT CODE: 1612586
PUBLISHER: 360iResearch | PRODUCT CODE: 1612586
Biopsy Guidance System Market by Product (MRI Guided Biopsy, Stereotactic Guided Biopsy, Ultrasound Guided Biopsy), Application (Brain Biopsy, Breast Biopsy, Lungs), End-Use - Global Forecast 2025-2030
The Biopsy Guidance System Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.54 billion in 2024, and is projected to grow at a CAGR of 7.34%, to USD 2.38 billion by 2030.
The biopsy guidance system market encompasses technologies and devices designed to improve the accuracy, safety, and efficiency of obtaining tissue samples for diagnostic purposes. These systems are crucial for detecting anomalies such as cancer, offering precise targeting and minimizing invasiveness. The necessity is underscored by the rising prevalence of cancer and other chronic diseases requiring accurate diagnostics, prompting healthcare facilities to adopt advanced guidance systems. Applications range from ultrasound, CT, MRI-guided biopsies to stereotactic and robotic-assisted procedures. End-users primarily include hospitals, diagnostic centers, and specialty clinics. Key factors influencing market growth include technological advancements in imaging, growing demand for minimally invasive procedures, and increasing awareness among healthcare professionals. However, challenges such as high equipment costs, regulatory hurdles, limited skilled personnel, and issues related to device standardization may impede growth. Opportunities abound in emerging markets with expanding healthcare infrastructure and increased government funding for cancer research. Companies can capitalize on these by investing in R&D to innovate cost-effective, portable, and user-friendly systems, expanding product portfolios through strategic collaborations, and focusing on training programs to enhance usability and adoption. In terms of limitations, the potential for adverse effects during procedures, coupled with stringent regulatory compliance requirements, pose significant barriers. Areas ripe for innovation include the development of AI-integrated systems for real-time image analysis, improved wireless communication between devices for enhanced accuracy, and the use of biodegradable materials for one-time use instruments. The market is dynamic with rapid technological evolution, yet it demands careful navigation through regulatory landscapes and persistent innovation to maintain competitive advantage. Businesses that prioritize understanding these landscapes and actively pursue strategic partnerships and technological advancements are best positioned to secure sustained growth.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.44 billion |
| Estimated Year [2024] | USD 1.54 billion |
| Forecast Year [2030] | USD 2.38 billion |
| CAGR (%) | 7.34% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopsy Guidance System Market
The Biopsy Guidance System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing incidences of cancer and chronic diseases requiring diagnostic procedures
- Increasing preference for minimally invasive biopsy treatments
- Government campaigns and initiatives for early disease diagnosis
- Market Restraints
- Need for specialized training and inaccuracy of biopsy systems
- Market Opportunities
- Technological advancements in biopsy guidance systems
- Favorable reimbursement policies for biopsy procedures
- Market Challenges
- Technical complexities associated with biopsy guidance system
Porter's Five Forces: A Strategic Tool for Navigating the Biopsy Guidance System Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopsy Guidance System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Biopsy Guidance System Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopsy Guidance System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Biopsy Guidance System Market
A detailed market share analysis in the Biopsy Guidance System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopsy Guidance System Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopsy Guidance System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Biopsy Guidance System Market
A strategic analysis of the Biopsy Guidance System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.
Market Segmentation & Coverage
This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across MRI Guided Biopsy, Stereotactic Guided Biopsy, and Ultrasound Guided Biopsy.
- Based on Application, market is studied across Brain Biopsy, Breast Biopsy, Lungs, and Prostate.
- Based on End-Use, market is studied across Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing incidences of cancer and chronic diseases requiring diagnostic procedures
- 5.1.1.2. Increasing preference for minimally invasive biopsy treatments
- 5.1.1.3. Government campaigns and initiatives for early disease diagnosis
- 5.1.2. Restraints
- 5.1.2.1. Need for specialized training and inaccuracy of biopsy systems
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in biopsy guidance systems
- 5.1.3.2. Favorable reimbursement policies for biopsy procedures
- 5.1.4. Challenges
- 5.1.4.1. Technical complexities associated with biopsy guidance system
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
- 5.2.2. Application: Improved applications for breast biopsies for enhanced accuracy
- 5.2.3. End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Biopsy Guidance System Market, by Product
- 6.1. Introduction
- 6.2. MRI Guided Biopsy
- 6.3. Stereotactic Guided Biopsy
- 6.4. Ultrasound Guided Biopsy
7. Biopsy Guidance System Market, by Application
- 7.1. Introduction
- 7.2. Brain Biopsy
- 7.3. Breast Biopsy
- 7.4. Lungs
- 7.5. Prostate
8. Biopsy Guidance System Market, by End-Use
- 8.1. Introduction
- 8.2. Diagnostic Centers
- 8.3. Hospitals
- 8.4. Research & Academic Institutes
- 8.5. Specialty Clinics
9. Americas Biopsy Guidance System Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Biopsy Guidance System Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Biopsy Guidance System Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. FDA Clears MRI-Compatible Robotics System for Breast Biopsy
- 12.3.2. Stryker Launches Q Guidance with Cranial Guidance Software
- 12.3.3. GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Argon Medical Devices, Inc.
- 2. Becton, Dickinson and Company
- 3. Bio-Rad Laboratories, Inc.
- 4. Biobot Surgical Pte Ltd.
- 5. Body Vision Medical Ltd.
- 6. Boston Scientific Corporation
- 7. Cardinal Health, Inc.
- 8. Cook Group Incorporated
- 9. Danaher Corporation
- 10. Fujifilm Holdings Corporation
- 11. GE Healthcare
- 12. Hologic, Inc.
- 13. IMS Giotto S.p.A
- 14. Inomed Health Limited
- 15. INRAD Inc.
- 16. IZI Medical Products
- 17. KOELIS
- 18. Koninklijke Philips N.V.
- 19. KPI Healthcare India pvt Ltd
- 20. Mauna Kea Technologies
- 21. Medtronic PLC
- 22. Merit Medical Systems
- 23. NeoDynamics AB
- 24. Olympus Corporation
- 25. Planmed Oy
- 26. Siemens Healthineers AG
- 27. STERYLAB S.r.l.
- 28. Stryker Corporation
- 29. Trivitron Healthcare
LIST OF FIGURES
- FIGURE 1. BIOPSY GUIDANCE SYSTEM MARKET RESEARCH PROCESS
- FIGURE 2. BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. BIOPSY GUIDANCE SYSTEM MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. BIOPSY GUIDANCE SYSTEM MARKET DYNAMICS
- TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 25. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 26. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 28. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 29. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 31. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 32. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 33. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 34. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 35. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 45. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 46. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 48. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 49. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 51. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 52. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 53. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 54. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 55. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 57. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 58. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 60. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 61. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 63. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 64. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 66. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 67. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 69. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 70. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 72. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 73. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 75. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 76. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 78. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 79. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 85. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 86. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 88. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 89. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 91. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 92. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 94. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 95. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 97. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 98. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 100. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 101. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 103. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 104. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 105. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 106. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 107. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 109. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 110. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 112. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 113. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 115. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 116. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 118. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 119. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 120. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 121. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 122. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 124. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 125. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 127. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 128. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 130. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 131. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 133. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 134. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 136. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 137. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 139. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 140. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 142. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 143. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 145. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 146. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 148. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 149. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
